These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26204834)

  • 1. What Do We Know about the Role of miRNAs in Pediatric Sarcoma?
    Kelly LC; Lázaro A; O'Sullivan MJ
    Int J Mol Sci; 2015 Jul; 16(7):16593-621. PubMed ID: 26204834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
    Smolle MA; Leithner A; Posch F; Szkandera J; Liegl-Atzwanger B; Pichler M
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs and Soft Tissue Sarcomas.
    Fujiwara T; Kunisada T; Takeda K; Ozaki T
    Adv Exp Med Biol; 2015; 889():179-99. PubMed ID: 26659002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory roles and therapeutic potential of microRNA in sarcoma.
    Lim HJ; Yang JL
    Crit Rev Oncol Hematol; 2016 Jan; 97():118-30. PubMed ID: 26318097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.
    Fujiwara T; Kunisada T; Takeda K; Uotani K; Yoshida A; Ochiya T; Ozaki T
    Biomed Res Int; 2014; 2014():592868. PubMed ID: 25165708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-mediated gene regulations in human sarcomas.
    Subramanian S; Kartha RV
    Cell Mol Life Sci; 2012 Nov; 69(21):3571-85. PubMed ID: 22922987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.
    Wong P; Hui A; Su J; Yue S; Haibe-Kains B; Gokgoz N; Xu W; Bruce J; Williams J; Catton C; Wunder JS; Andrulis IL; Gladdy R; Dickson B; O'Sullivan B; Liu FF
    Oncotarget; 2015 Nov; 6(36):39127-39. PubMed ID: 25970788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression signature of human sarcomas.
    Subramanian S; Lui WO; Lee CH; Espinosa I; Nielsen TO; Heinrich MC; Corless CL; Fire AZ; van de Rijn M
    Oncogene; 2008 Mar; 27(14):2015-26. PubMed ID: 17922033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling of primary high-grade soft tissue sarcomas.
    Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
    Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of altered MicroRNA expression patterns in synovial sarcoma.
    Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
    Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-MED: sarcoma microRNA expression database.
    Sarver AL; Phalak R; Thayanithy V; Subramanian S
    Lab Invest; 2010 May; 90(5):753-61. PubMed ID: 20212452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.
    Sachdeva M; Whitley MJ; Mito JK; Ma Y; Lev DC; Cardona DM; Kirsch DG
    Dis Model Mech; 2015 Aug; 8(8):867-75. PubMed ID: 26044957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.